Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.

Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong KK, Chin L.

Nature. 2009 Jun 25;459(7250):1085-90. doi: 10.1038/nature08109.

2.

mTOR as a positive regulator of tumor cell responses to hypoxia.

Abraham RT.

Curr Top Microbiol Immunol. 2004;279:299-319. Review.

PMID:
14560965
3.

New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists.

Carraway H, Hidalgo M.

Breast Cancer Res. 2004;6(5):219-24. Epub 2004 Aug 12. Review.

4.

An expanding role for mTOR in cancer.

Guertin DA, Sabatini DM.

Trends Mol Med. 2005 Aug;11(8):353-61. Review.

PMID:
16002336
5.

Targeting mTOR globally in cancer: thinking beyond rapamycin.

Shor B, Gibbons JJ, Abraham RT, Yu K.

Cell Cycle. 2009 Dec;8(23):3831-7. Epub 2009 Dec 14. Review.

PMID:
19901542
6.

mTOR pathway as a target in tissue hypertrophy.

Lee CH, Inoki K, Guan KL.

Annu Rev Pharmacol Toxicol. 2007;47:443-67. Review.

PMID:
16968213
7.

mTOR as a target for cancer therapy.

Houghton PJ, Huang S.

Curr Top Microbiol Immunol. 2004;279:339-59. Review.

PMID:
14560967
8.

Current status and challenges associated with targeting mTOR for cancer therapy.

Dowling RJ, Pollak M, Sonenberg N.

BioDrugs. 2009;23(2):77-91. doi: 10.2165/00063030-200923020-00002. Review.

PMID:
19489650
9.

Making new contacts: the mTOR network in metabolism and signalling crosstalk.

Shimobayashi M, Hall MN.

Nat Rev Mol Cell Biol. 2014 Mar;15(3):155-62. doi: 10.1038/nrm3757. Review.

PMID:
24556838
10.

GOLPH3 and oncogenesis: What is the molecular link?

Rizzo R, Parashuraman S, D'Angelo G, Luini A.

Tissue Cell. 2017 Apr;49(2 Pt A):170-174. doi: 10.1016/j.tice.2016.06.008. Epub 2016 Jun 17. Review.

PMID:
27378035
11.

The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3.

Sechi S, Frappaolo A, Belloni G, Colotti G, Giansanti MG.

Oncotarget. 2015 Feb 28;6(6):3493-506. Review.

12.

The GOLPH3 pathway regulates Golgi shape and function and is activated by DNA damage.

Buschman MD, Xing M, Field SJ.

Front Neurosci. 2015 Oct 7;9:362. doi: 10.3389/fnins.2015.00362. eCollection 2015. Review.

Supplemental Content

Support Center